Anaplastic large cell lymphoma pediatric · 1 regimen
Cost vs Efficacy · 1 point
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Crizotinib monotherapy Variant #01 | — | R 119 525 | 28d | ~11.1 mo | — | ~13 | ~R 1 553 824 PFS proxy · indirect | 12 |
1 of 1 regimen shown